✦ LIBER ✦

Phase II safety and immunogenicity study of type F botulinum toxoid in adult volunteers

✍ Scribed by Robert Edelman; Steven S Wasserman; Sacared A Bodison; Judith G Perry; Michael O’Donnoghue; Louis J DeTolla Jr.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label, single-arm, phase I study

✍ Namhee Kim; Gyoungjin Choi; Chi-Yeon Lim; Jae-Won Lee; Kyung-Hyo Kim; Hoan Jong 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 367 KB

Safety and immunogenicity of an inactiva

✍ G. Wiedermann; F. Ambrosch; H. Kollaritsch; H. Hofmann; Ch. Kunz; E. D'Hondt; A. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 375 KB

Safety and Immunogenicity of an Intramus

✍ Peter Malfertheiner; Viola Schultze; Bernd Rosenkranz; Stefan H.E. Kaufmann; Tim 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 766 KB

Phase I/II studies to evaluate safety an

✍ Moutschen, Michel (author);Léonard, Philippe (author);Sokal, Etienne M. (author) 📂 Article 📅 2007 🏛 Elsevier BV 🌐 English ⚖ 148 KB

Phase II, dose ranging study of the safe

✍ Gustavo H. Dayan; Joan Bevilacqua; Dorothy Coleman; Aileen Buldo; George Risi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 642 KB

Phase I study of the immunogenicity and

✍ Elizabeth Kantor; Jay S. Luxenberg; Alexander H. Lucas; Dan M. Granoff 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 496 KB